The report that followed was published this week and has been welcomed by the Academy of Medical Royal Colleges. Notably the report urges Government to seek to secure the closest possible regulatory alignment with the EU for medicines and devices in the Brexit negotiations.
In response to the report, Professor Alan Boyd who is leading the Academy’s work on Brexit and medicines regulation, said, “Everyone who participated in this inquiry from their comments, or at the hearings, gave the same message that the UK, through the Medicines and Healthcare products Regulatory Agency, should have a continued relationship with the European Medicines Agency (EMA). Today’s report from the Health and Social Care Select Committee also delivers the same message to Government; that both the UK and the EU27 should be looking to secure this continued relationship. This is in the best interests of patients across the whole of Europe and politics should not get in the way of achieving this outcome.”
To read the full report, click here.